Literature DB >> 6421919

Nutrition by hypodermoclysis.

E Y Berger.   

Abstract

It is possible to administer fluid subcutaneously at a rate so slow that the forces of diffusion and perfusion are able to transfer that fluid to the circulation at a rate equal to the rate of its delivery. In clinical practice, fluid can be delivered subcutaneously in the presence of hyaluronidase at about 1 ml per minute without the accumulation of edema. Thus, 1500 ml can be delivered in 24 hours at a single site, and 3000 ml of fluid can be delivered at two sites in 24 hours. This procedure, called hypodermoclysis, is used for hydration. It is particularly useful for the aged patient in the long-term care institution when it will save the patient from the dangers of hospitalization and save society from its costs.

Entities:  

Mesh:

Year:  1984        PMID: 6421919     DOI: 10.1111/j.1532-5415.1984.tb02002.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

1.  Assessment of sterility in fluid bags maintained for chronic use.

Authors:  Kristin A Matthews; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Hypodermoclysis for symptom control in terminal care.

Authors:  H Hays
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

Review 3.  Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients.

Authors:  A Frisoli Junior; A P de Paula; D Feldman; F Nasri
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

4.  A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients.

Authors:  Y C Challiner; D Jarrett; M J Hayward; M A al-Jubouri; S A Julious
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

5.  Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?

Authors:  Sasson Menahem; Pesach Shvartzman
Journal:  Support Care Cancer       Date:  2009-09-30       Impact factor: 3.603

6.  Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.

Authors:  Samuel S Dychter; David Ebel; Tonya R Mead; Richard C Yocum
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

7.  Subcutaneous injection-induced cellulites.

Authors:  Kao-Chi Cheng; Po-Tsung Huang; Chiu-Shong Liu; Wen-Yuan Lin
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

8.  Effectiveness and Safety of Hypodermoclysis Patients With Cancer: A Single-Center Experience From Saudi Arabia.

Authors:  Sittelbenat Adem; Nabil ALMouaalamy
Journal:  Cureus       Date:  2021-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.